Serina Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $130 | $0 | $-14 | $14 |
Gross Profit | 114 | -17 | -70 | -42 |
EBITDA | -6,437 | -4,805 | -2,679 | 1,454 |
EBIT | -6,453 | -4,822 | -2,735 | 1,398 |
Net Income | -6,448 | -4,813 | -2,740 | 1,410 |
Net Change In Cash | 130 | 0 | -14 | 14 |
Free Cash Flow | -3,750 | -4,322 | -4,594 | -2,965 |
Cash | 6,041 | 4,267 | 3,672 | 3,185 |
Basic Shares | 10,004 | 9,756 | 10,751 | 10,751 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $56 | $3,153 | $500 | $3,039 |
Gross Profit | -138 | 3,063 | 355 | -110 |
EBITDA | -10,487 | 5,917 | -7,055 | -7,354 |
EBIT | -10,681 | 5,827 | -7,187 | -7,485 |
Net Income | -11,141 | 5,269 | -2,682 | -1,264 |
Net Change In Cash | 56 | 3,153 | 500 | 3,039 |
Free Cash Flow | -17,159 | -2,980 | -2,085 | -2,359 |
Cash | 3,672 | 345 | 532 | 314 |
Basic Shares | 7,359 | 8,413 | 1,078 | 1,077 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.66 |
2025-03-31 | -$0.49 |
2024-12-31 | -$0.35 |
2024-09-30 | $0.13 |
